Rexcel Pharmaceuticals Limited
About Rexcel Pharmaceuticals Limited
Data last updated:
Rexcel Pharmaceuticals Limited was a public limited company based in New Delhi, Delhi, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharmaceutical chemical segment of the chemicals sector. It was incorporated on 03 March 1997.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1997PLC085491.
The company had an authorised share capital of ₹15 Cr and a paid-up capital of ₹12.5 Cr. It was led by directors including Sanjeev Indravadan Dani and Ranjit Kohli.
Its last annual general meeting (AGM) was held on 10 May 2012, and its latest financial statements are for the year ended 31 December 2011. The registered office was at 12th Floor Devika Tower Nehru Place, New Delhi, Delhi, India – 110019.
Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it; 1 case is pending.
Company details
Contact details
Rexcel Pharmaceuticals Limited's registered office is in New Delhi, Delhi.
- Registered Address12th Floor Devika Tower Nehru Place, New Delhi, Delhi, India – 110019
- IndustryChemicals, Pharmaceutical Chemical, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rexcel Pharmaceuticals Limited
FY 2011 filings availableFinancial Statement Summary
| Metrics | FY 2010-11 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2010-11 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Rexcel Pharmaceuticals Limited, buy the company report.
Board of directors of Rexcel Pharmaceuticals Limited
Rexcel Pharmaceuticals has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Indravadan Dani | Director | 28 Jul 2005 | 21 Years 3 Months | As last reported |
| Ashwani Kumar Malhotra Also directs: Garvfit Athletic Performance LLP | Nominee Director | 01 Nov 2010 | 16 Years 0 Months | As last reported |
| Ranjit Kohli | Director | 12 Mar 2012 | 14 Years 8 Months | As last reported |
| Sandeep Mehandroo | Director | 30 Jan 2008 | 18 Years 9 Months | As last reported |
Legal cases
Rexcel Pharmaceuticals Limited has 5 court cases on record: 3 filed by Rexcel Pharmaceuticals, 2 filed against it. 1 case is pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 2 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Calcutta High Court | Court case (FAT) | Filed by the company against an individual | Pending |
| High Court of Delhi | Court case (CO.APPL.(M)) | Filed by the company | Disposed |
| High Court of Delhi | Court case (CO.PET.) | Filed by the company | Disposed |
| Calcutta High Court | Court case (CO) | Filed against the company by an individual | Disposed |
| High Court of Madhya Pradesh | Writ petition | Filed against the company by an individual | Disposed |
To see the full case history of Rexcel Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rexcel Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rexcel Pharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rexcel Pharmaceuticals Limited has 11 board changes on record since 2005: 4 appointments and 7 cessations. The latest: Ranjit Kohli ceased to be Additional Director on 10 May 2012.
2 earlier events are in the company report.
Frequently asked questions
Rexcel Pharmaceuticals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Rexcel Pharmaceuticals was a public limited company based in New Delhi, Delhi, India. The company worked in pharmaceutical chemical, within the chemicals industry. It was incorporated on 03 March 1997 and is registered under CIN U24231DL1997PLC085491. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Rexcel Pharmaceuticals was incorporated on 03 March 1997. It is registered with the Registrar of Companies, Delhi.
Rexcel Pharmaceuticals had 4 directors:
- Sanjeev Indravadan Dani - Director
- Ashwani Kumar Malhotra - Nominee Director
- Ranjit Kohli - Director
- Sandeep Mehandroo - Director
The CIN (Corporate Identification Number) of Rexcel Pharmaceuticals is U24231DL1997PLC085491. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Rexcel Pharmaceuticals is at 12th Floor Devika Tower Nehru Place, New Delhi, Delhi, India – 110019.
The latest financial statements of Rexcel Pharmaceuticals on record with the MCA are for the year ended 31 December 2011. Its last annual general meeting was held on 10 May 2012. Year-wise statements from 2015 are in the company report.
Rexcel Pharmaceuticals operated in the chemicals industry, in the pharmaceutical chemical segment.
Rexcel Pharmaceuticals has 5 court cases on record: 3 filed by the company and 2 filed against it. 1 is pending.
Ranjit Kohli ceased to be Additional Director on 10 May 2012. Ranjit Kohli was appointed as Director on 12 Mar 2012. Sanjeev Mahna ceased to be Nominee Director on 12 Mar 2012. Rexcel Pharmaceuticals has 11 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
